Lance Zeimetz v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2023)
Case summary [AI summaries can sometimes make mistakes]
Lance Zeimetz filed a petition for compensation under the National Vaccine Injury Compensation Program on December 2, 2021, alleging that he suffered from Guillain-Barre Syndrome (GBS) as a result of an influenza vaccine he received on October 9, 2019. The respondent conceded that Mr.
Zeimetz is entitled to compensation, agreeing that he suffered from GBS and met the criteria for a Table injury. The respondent's position was that the onset of GBS occurred between three and forty-two days after the vaccination, with no more likely alternative diagnosis or apparent alternative cause.
A ruling on entitlement was issued on March 13, 2023, finding Mr. Zeimetz entitled to compensation.
Subsequently, on August 3, 2023, the respondent filed a proffer on award of compensation, which Mr. Zeimetz agreed with.
The decision on damages, issued on September 5, 2023, awarded Mr. Zeimetz a lump sum payment of $182,233.01, which included $172,500.00 for pain and suffering and $9,733.01 for out-of-pocket medical and related expenses.
Mr. Zeimetz is a competent adult.